ARYD

ARYA Sciences Acquisitio... (ARYD)

ARYA Sciences Acquisition Corporation IV

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ARYD

1 2 3 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/21	10 : 31	Edgar (US Regulatory)	Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
2024/05/21	06 : 25	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
2024/05/17	05 : 41	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
2024/05/17	05 : 15	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
2024/05/06	19 : 25	GlobeNewswire Inc.	Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd Wider	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
2024/02/29	07 : 25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
2024/02/29	07 : 02	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
2024/02/27	06 : 48	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
2024/02/27	06 : 46	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
2024/02/16	06 : 34	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
2024/02/16	06 : 33	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
2024/02/15	06 : 16	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
2024/02/15	06 : 15	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
2024/02/14	22 : 51	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
2024/02/14	20 : 29	PR Newswire (US)	Adagio Medical To List on Nasdaq Through Business Combination with ARYA Sciences Acquisition Corp IV, Enabling Further Commercial and Clinical Development of Innovative Cardiac Ablation Technologies	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
2024/02/14	20 : 06	PR Newswire (US)	Adagio Medical To List on Nasdaq Through Business Combination with ARYA Sciences Acquisition Corp IV, Enabling Further Commercial and Clinical Development of Innovative Cardiac Ablation Technologies	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
2024/02/10	06 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
2024/02/02	23 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
2024/02/02	07 : 08	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
2024/01/31	06 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
2024/01/23	07 : 20	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
2024/01/02	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
2023/12/04	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
2023/11/10	06 : 30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
2023/11/03	05 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
2023/10/03	06 : 13	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
2023/09/28	05 : 47	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
2023/09/05	19 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
2023/08/12	05 : 30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV
2023/08/03	05 : 50	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ARYD	ARYA Sciences Acquisition Corporation IV